BMD and fracture effects of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone mass

Jean-Yves Reginster; D. Felsenberg; C. C. Gluer; J. Stepan; H. Schmitt; D. Quail; I. Pavo; T. Nickelsen

$BMD and fracture effects of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone mass$

Conference proceeding

Peer reviewed

BMD and fracture effects of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone mass

Jean-Yves Reginster, D. Felsenberg, C. C. Gluer, J. Stepan, H. Schmitt, D. Quail, I. Pavo and T. Nickelsen

Osteoporosis International, 13 (S1), S18-19 (2002); 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Barcelone, Spain [ES], Du 6 au 9 novembre 2002

2002

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: BMD and fracture effects of monofluorophosphate (MFP) combined with raloxifene (RLX) as compared to MFP alone in postmenopausal women with low bone mass
Creators - without role: Jean-Yves Reginster
D. Felsenberg
C. C. Gluer
J. Stepan
H. Schmitt
D. Quail
I. Pavo
T. Nickelsen
Conference: Osteoporosis International, 13 (S1), S18-19 (2002); 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Barcelone, Spain [ES], Du 6 au 9 novembre 2002
Publisher: Springer Science & Business Media B.V
Identifiers: 9951802708331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding